These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17551324)

  • 1. Lack of evidence for appetitive effects of Delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents.
    Vlachou S; Nomikos GG; Stephens DN; Panagis G
    Behav Pharmacol; 2007 Jul; 18(4):311-9. PubMed ID: 17551324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of delta9-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress.
    Fokos S; Panagis G
    J Psychopharmacol; 2010 May; 24(5):767-77. PubMed ID: 19406854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol.
    Gardner EL; Paredes W; Smith D; Donner A; Milling C; Cohen D; Morrison D
    Psychopharmacology (Berl); 1988; 96(1):142-4. PubMed ID: 2852376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.
    Lepore M; Vorel SR; Lowinson J; Gardner EL
    Life Sci; 1995; 56(23-24):2073-80. PubMed ID: 7776834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.
    Lepore M; Liu X; Savage V; Matalon D; Gardner EL
    Life Sci; 1996; 58(25):PL365-72. PubMed ID: 8649214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Δ
    Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):111-120. PubMed ID: 36179013
    [No Abstract]   [Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.
    Braida D; Iosuè S; Pegorini S; Sala M
    Eur J Pharmacol; 2004 Dec; 506(1):63-9. PubMed ID: 15588625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of footshock stress on place conditioning produced by Δ
    DeVuono MV; Wills KL; MacPherson DV; Hrelja KM; Parker LA
    Psychopharmacology (Berl); 2017 Nov; 234(21):3229-3240. PubMed ID: 28803323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus.
    Katsidoni V; Anagnostou I; Panagis G
    Addict Biol; 2013 Mar; 18(2):286-96. PubMed ID: 22862835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent delta-9-tetrahydrocannabinol (THC) exposure fails to affect THC-induced place and taste conditioning in adult male rats.
    Wakeford AG; Flax SM; Pomfrey RL; Riley AL
    Pharmacol Biochem Behav; 2016 Jan; 140():75-81. PubMed ID: 26577749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta(9)-THC administered into the medial prefrontal cortex disrupts the spatial working memory.
    Silva de Melo LC; Cruz AP; Rios Valentim SJ; Marinho AR; Mendonça JB; Nakamura-Palacios EM
    Psychopharmacology (Berl); 2005 Nov; 183(1):54-64. PubMed ID: 16163518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.
    Leitl MD; Negus SS
    Behav Pharmacol; 2016 Jun; 27(4):364-76. PubMed ID: 26588213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
    Solinas M; Zangen A; Thiriet N; Goldberg SR
    Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ
    Han X; He Y; Bi GH; Zhang HY; Song R; Liu QR; Egan JM; Gardner EL; Li J; Xi ZX
    Sci Rep; 2017 Sep; 7(1):12315. PubMed ID: 28951549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F; Roques BP; Noble F
    Behav Brain Res; 2006 Oct; 173(2):255-61. PubMed ID: 16884789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of delta 9-tetrahydrocannabinol on the extinction of an adverse associative memory.
    Ashton JC; Smith PF; Darlington CL
    Pharmacology; 2008; 81(1):18-20. PubMed ID: 17726344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.